Pharmaceuticals News and Research

RSS

Ranbaxy receives approval to manufacture Pravastatin Sodium tablets in U.S.

Ranbaxy Pharmaceuticals has announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Pravastatin Sodium Tablets (Pravastatin), 10 mg, 20 mg, 40 mg and 80 mg, with 180-day market exclusivity in the U.S. healthcare system for the 80 mg strength.

27 Apr 2007

Inex Pharmaceuticals announces expected completion date for Tekmira Pharmaceuticals Corporation

Inex Pharmaceuticals Corporation has announced that it expects the closing of the spin-out of Tekmira Pharmaceuticals Corporation ("Tekmira") to occur at the close of business on April 30, 2007.

27 Apr 2007

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.

27 Apr 2007

Under the microscope...doctors' relationships with drug companies

According to a recent survey almost all doctors in the U.S. have some form of relationship with drug companies.

26 Apr 2007

Physician ties to drug industry stronger than ever

Despite the potential for conflict of interest, virtually all practicing physicians in the U.S. have some form of relationship with pharmaceutical manufacturers but the nature and extent of those relationships vary, depending on the kind of practice, medical specialty, patient mix, and professional activities, reports a study in the April 26 issue of the New England Journal of Medicine.

26 Apr 2007

Wyeth Pharmaceuticals receives FDA approvable for Bazedoxifene for the prevention of postmenopausal osteoporosis

Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for bazedoxifene, a selective estrogen receptor modulator (SERM) for the prevention of postmenopausal osteoporosis.

26 Apr 2007

Researchers study the possible use of carboranes

When protein plaque builds up in the blood, it can result in serious diseases such as heart disease and Alzheimer's.

25 Apr 2007

Neuromed licenses chronic pain product from ALZA Corporation

Neuromed Pharmaceuticals has announced that it has licensed from ALZA Corporation the exclusive U.S. rights to develop and commercialize OROS(R) Hydromorphone, an extended release formulation of a potent opioid analgesic in Phase 3 clinical development.

25 Apr 2007

Drug company sales visits influenced doctors

Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.

25 Apr 2007

Shire completes aquisition of New River

Shire plc has announced that it has completed its acquisition of New River Pharmaceuticals Inc.

24 Apr 2007

New system for restoring damaged or lost knee cartilage tissue

Knee osteoarthritis affects 30 million people worldwide, causing pain and joint stiffness and in severe cases restricted mobility.

24 Apr 2007

Chitin compound causes allergic inflammation

The beetle's back and the crab's shell owe their toughness to a common compound called chitin that now appears to trigger airway inflammation and possibly asthma, UCSF scientists have found.

24 Apr 2007

Mixing certain allergy medications with other medicines can have hazardous effects on your health

Allergy season is here, and over-the-counter allergy medications are flying off the shelves.

24 Apr 2007

Spousal choices can influence alcohol dependence

Alcohol dependence (AD) is more common among partners of alcoholics than among partners of non-alcoholics.

24 Apr 2007

Mylan anounces FDA approval of Zolpidem Tartrate tablets

Mylan Laboratories has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Zolpidem Tartrate Tablets, 5 mg and 10 mg.

24 Apr 2007

FDA approves generic versions of Ambien

The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

24 Apr 2007

FDA approves Alpharma's KADIAN 10mg strength capsule

Alpharma Inc. has announced that it has been notified by the United States Food and Drug Administration(FDA) that its pending application for KADIAN 10mg strength capsule has received approval.

24 Apr 2007

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Avicena Group has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), a severe neurodegenerative disease.

24 Apr 2007

Thailand wins round two in battle to access cheaper AIDS drugs

The military government in Thailand has won the second round in it's battle to access cheaper AIDS drugs for the nations 580,000 AIDS sufferers.

23 Apr 2007

Benefits of antidepressants for children far outweigh the risks

Researchers in the United States maintain that a review of research shows that the benefits of antidepressants for children and teens during the first few months of treatment far outweigh the risk of suicide.

22 Apr 2007